Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PRINCIPEN vs PRINCIPEN '500'
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Ampicillin, a beta-lactam antibiotic, inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) and interfering with transpeptidation, leading to cell lysis.
Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Infections of the respiratory tract (e.g., sinusitis, bronchitis, pneumonia) caused by susceptible organisms,Infections of the genitourinary tract (e.g., urinary tract infections, gonorrhea) caused by susceptible organisms,Infections of the gastrointestinal tract (e.g., typhoid fever, shigellosis) caused by susceptible organisms,Meningitis caused by susceptible organisms (e.g., Listeria monocytogenes, Neisseria meningitidis),Endocarditis (e.g., enterococcal endocarditis) - in combination with an aminoglycoside,Septicemia caused by susceptible organisms,Prophylaxis of bacterial endocarditis in patients undergoing dental or surgical procedures (off-label in some guidelines)
Infections of the respiratory tract,Genitourinary tract infections,Meningitis,Septicemia,Endocarditis,Gastrointestinal infections,Skin and soft tissue infections,Prophylaxis for bacterial endocarditis (off-label)
250-500 mg orally every 6 hours or 500 mg intravenously every 6 hours for moderate infections; severe infections: 500 mg-1 g every 4-6 hours.
500 mg orally every 6 hours for 7-14 days for mild to moderate infections; for severe infections, 500 mg orally every 4 hours.
0.5–1 hour; prolonged to 7–10 hours in renal impairment (creatinine clearance <10 m L/min).
0.5–1 hour; prolonged in renal impairment (up to 10 hours in anuria).
Ampicillin is partially metabolized by hepatic hydrolysis to penicilloic acid; approximately 90% of an oral dose is excreted unchanged in urine via tubular secretion and glomerular filtration.
Ampicillin is metabolized primarily by hydrolysis to penicilloic acid; hepatic metabolism is minimal.
Primarily renal (90–100% unchanged) via tubular secretion and glomerular filtration. Minor biliary excretion (<1%).
Primarily renal (90% unchanged via glomerular filtration and tubular secretion); small amounts biliary/fecal (<5%).
60–80% bound to albumin.
~20% bound to serum albumin.
0.3–0.5 L/kg; indicates limited extravascular distribution.
0.2–0.3 L/kg; limited to extracellular fluid.
Oral: 30–50% (variable due to gastric acid lability); IM: 70–85%.
IM: 100% (complete); PO: 30–60% (acid-labile, variable).
Cr Cl >50 m L/min: no adjustment; Cr Cl 10-50 m L/min: 250-500 mg every 6-8 hours; Cr Cl <10 m L/min: 250-500 mg every 12 hours; hemodialysis: 250-500 mg every 12 hours, give dose after dialysis.
For Cr Cl 30-50 m L/min: administer 500 mg every 8 hours; Cr Cl 10-30 m L/min: 500 mg every 12 hours; Cr Cl <10 m L/min: 500 mg every 24 hours.
No adjustment required for mild to moderate hepatic impairment; caution in severe hepatic disease due to potential for accumulation, but specific Child-Pugh adjustments not established.
No specific adjustment required for hepatic impairment; caution in severe hepatic disease due to potential risk of crystalluria.
Neonates 0-7 days: 50-100 mg/kg/day IV divided every 12 hours; Infants 1-4 weeks: 75-150 mg/kg/day IV divided every 8 hours; Children >1 month: 25-50 mg/kg/day orally divided every 6 hours, or 100-200 mg/kg/day IV divided every 4-6 hours; maximum 12 g/day.
For children >1 month: 12.5-25 mg/kg/dose orally every 6 hours; maximum 2 g/day. For neonates: 25 mg/kg/dose every 8 hours.
No specific dose adjustment required; consider age-related renal impairment and adjust based on renal function; monitor for electrolyte disturbances and neurotoxicity.
Adjust based on renal function; monitor for crystalluria and superinfection; standard dosing if Cr Cl >50 m L/min.
None
No FDA black box warning.
Serious and occasionally fatal hypersensitivity reactions (anaphylaxis) have been reported; discontinue therapy if reaction occurs.,Clostridium difficile-associated diarrhea (CDAD) may occur, ranging in severity from mild diarrhea to fatal colitis.,Prolonged use may result in overgrowth of nonsusceptible organisms (e.g., Candida).,Use with caution in patients with renal impairment; dose adjustment may be necessary.,Use with caution in patients with history of allergies (e.g., asthma, hay fever, urticaria) due to increased risk of hypersensitivity.
Serious hypersensitivity reactions (anaphylaxis) may occur,Clostridium difficile-associated diarrhea (CDAD),Seizures may occur in patients with renal impairment or high doses,Prolonged use may result in superinfection,Risk of bleeding abnormalities with high doses
Hypersensitivity to ampicillin or any other beta-lactam antibiotic (e.g., penicillins, cephalosporins),Infectious mononucleosis (high incidence of maculopapular rash)
Hypersensitivity to ampicillin, penicillins, or any component of the formulation,Infections caused by beta-lactamase-producing organisms
Food decreases absorption; take on an empty stomach. Avoid acidic beverages (e.g., citrus juices) which may degrade the drug. No specific dietary restrictions.
Avoid acidic beverages (e.g., fruit juices, soda) within 1 hour of taking ampicillin, as they may reduce absorption. Take on an empty stomach to maximize bioavailability. No specific dietary restrictions required.
FDA Pregnancy Category B. Animal studies have not revealed evidence of fetal harm. No adequate, well-controlled studies in pregnant women. However, penicillin-class antibiotics are generally considered low risk. First trimester: No documented teratogenicity. Second and third trimesters: No documented fetal adverse effects. Use only if clearly needed.
Pregnancy Category B. Animal studies have not demonstrated fetal risk, but no adequate human studies in pregnant women. Use only if clearly needed. No evidence of teratogenicity in first trimester; theoretical risk of diarrhea or rash in neonates if administered near term.
Ampicillin is excreted into human breast milk in low concentrations (M/P ratio approximately 0.2-0.3). The American Academy of Pediatrics considers ampicillin compatible with breastfeeding. Potential for alteration of infant gut flora and interference with culture results if febrile. Use caution in infants with known penicillin allergy.
Ampicillin is excreted into breast milk in low concentrations (M/P ratio ~0.05–0.2). Compatible with breastfeeding; may cause diarrhea or rash in infant. Monitor for gastrointestinal effects or sensitization.
No clinically significant pharmacokinetic changes requiring dose adjustment in pregnancy. Standard adult dosing is appropriate. For severe infections, higher doses may be needed due to increased volume of distribution and renal clearance, but no specific dose adjustment is routinely recommended.
Physiologic changes in pregnancy (increased plasma volume, renal clearance) may reduce serum ampicillin concentrations; consider higher doses (e.g., 500 mg every 6 hours) for standard infections, but no specific dose adjustment recommendations exist. Monitor clinical response.
Principen (ampicillin) is a penicillinase-sensitive penicillin. For empiric coverage, consider local resistance patterns; many E. coli and H. influenzae isolates are resistant. Administer on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Monitor for hypersensitivity reactions, especially in patients with penicillin allergy. Use with caution in mononucleosis due to high rash incidence.
Principen '500' (ampicillin) is a penicillin-class antibiotic with activity against gram-positive cocci (except penicillinase-producing staphylococci) and some gram-negative bacilli. Use caution in patients with penicillin allergy; cross-reactivity with cephalosporins occurs in ~1% of cases. Monitor for rash, which can be maculopapular (commonly in patients with mononucleosis) or urticarial. Dose adjustment required in renal impairment (Cr Cl <30 m L/min). Administer on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Avoid concurrent use with allopurinol due to increased risk of ampicillin rash.
Take on an empty stomach, at least 1 hour before or 2 hours after meals.,Complete the full course even if you feel better.,Notify your doctor if you develop a rash, diarrhea, or difficulty breathing.,Do not take if you are allergic to penicillins or cephalosporins.,Store capsules and oral suspension at room temperature; discard unused suspension after 14 days.
Take ampicillin exactly as prescribed, even if you feel better.,Take on an empty stomach (1 hour before or 2 hours after meals) with a full glass of water.,Finish the entire course of treatment; do not stop early unless directed by your doctor.,Inform your doctor if you have a penicillin allergy, kidney disease, or mononucleosis.,Contact your doctor if you develop severe diarrhea, rash, or difficulty breathing.,Ampicillin may reduce the effectiveness of oral contraceptives; use additional birth control methods.,Store at room temperature away from moisture and heat.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about PRINCIPEN vs PRINCIPEN '500', answered by our medical review team.
PRINCIPEN is a Aminopenicillin Antibiotic that works by Ampicillin, a beta-lactam antibiotic, inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) and interfering with transpeptidation, leading to cell lysis.. PRINCIPEN '500' is a Aminopenicillin Antibiotic that works by Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PRINCIPEN and PRINCIPEN '500' depend on the specific clinical indication. These are both Aminopenicillin Antibiotic agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PRINCIPEN is: 250-500 mg orally every 6 hours or 500 mg intravenously every 6 hours for moderate infections; severe infections: 500 mg-1 g every 4-6 hours.. The standard adult dose of PRINCIPEN '500' is: 500 mg orally every 6 hours for 7-14 days for mild to moderate infections; for severe infections, 500 mg orally every 4 hours.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PRINCIPEN and PRINCIPEN '500' in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PRINCIPEN is classified as Category C. FDA Pregnancy Category B. Animal studies have not revealed evidence of fetal harm. No adequate, well-controlled studies in pregnant women. However, penicillin-class antibiotics are. PRINCIPEN '500' is classified as Category C. Pregnancy Category B. Animal studies have not demonstrated fetal risk, but no adequate human studies in pregnant women. Use only if clearly needed. No evidence of teratogenicity in. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.